Outcomes and treatment patterns of adding a third agent to 2OADs in patients with type 2 diabetes


Levin P., Wei W., Xie L., BAŞER O., Zhou S.

JOURNAL OF MANAGED CARE PHARMACY : JMCP, cilt.20, ss.501-512, 2014 (SCI-Expanded, Scopus)